Capital Advisors Inc. OK Has $60.47 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital Advisors Inc. OK cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 122,086 shares of the medical equipment provider's stock after selling 7,665 shares during the period. Intuitive Surgical makes up approximately 1.2% of Capital Advisors Inc. OK's holdings, making the stock its 20th biggest position. Capital Advisors Inc. OK's holdings in Intuitive Surgical were worth $60,466,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of ISRG. Atala Financial Inc bought a new position in Intuitive Surgical during the 4th quarter valued at about $25,000. Chilton Capital Management LLC raised its stake in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 43 shares during the last quarter. Parvin Asset Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $26,000. Global Financial Private Client LLC raised its stake in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 38 shares during the last quarter. Finally, Elite Financial Inc. bought a new position in shares of Intuitive Surgical in the first quarter worth about $26,000. 83.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Barclays dropped their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Citigroup reaffirmed a "buy" rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Evercore ISI boosted their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research note on Tuesday. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price target for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $592.59.

Intuitive Surgical Trading Down 0.2%

Shares of ISRG stock traded down $0.82 during trading hours on Wednesday, hitting $526.48. 465,685 shares of the company were exchanged, compared to its average volume of 1,667,414. The business has a 50 day moving average of $537.77 and a two-hundred day moving average of $536.93. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00. The company has a market capitalization of $188.70 billion, a PE ratio of 77.34, a PEG ratio of 5.67 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the prior year, the firm earned $1.50 earnings per share. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the transaction, the director owned 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the transaction, the executive vice president owned 5,224 shares of the company's stock, valued at $2,695,113.84. The trade was a 3.47% decrease in their position. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock worth $2,611,577 over the last three months. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.